🔗 Share this article

This year's Nobel Prize in medical science was granted for revolutionary discoveries that clarify how the body's defense network attacks dangerous pathogens while protecting the body's own cells.

A trio of renowned researchers—from Japan Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this accolade.

The research identified specialized "sentinels" within the immune system that remove malfunctioning immune cells that could attacking the body.

The discoveries are now paving the way for innovative therapies for immune disorders and cancer.

The winners will divide a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"The work has been decisive for comprehending how the body's defenses operates and why we don't all develop serious self-attack conditions," commented the head of the Nobel Committee.

The trio's studies address a core question: In what way does the defense system protect us from countless infections while keeping our healthy cells unharmed?

The immune system uses immune cells that scan for indicators of disease, including viruses and germs it has never encountered.

These cells employ sensors—called recognition units—that are produced randomly in a vast number of combinations.

This provides the defense network the capacity to combat a broad range of threats, but the randomness of the mechanism inevitably creates immune cells that may target the host.

Security Guards of the Immune System

Researchers earlier understood that a portion of these problematic defense cells were eliminated in the thymus—where white blood cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—known as the immune system's "security guards"—which travel through the body to neutralize any defenders that attack the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

A prize committee stated, "These findings have established a new field of investigation and accelerated the development of new therapies, for instance for tumors and immune disorders."

Regarding malignancies, T-regs block the body from fighting the growth, so studies are focused on lowering their quantity.

In self-attack disorders, experiments are exploring increasing T-reg cells so the body is not under attack. A comparable approach could also be useful in minimizing the chances of transplanted organ rejection.

Pioneering Experiments

Prof Sakaguchi, of a Japanese institution, performed tests on rodents that had their thymus removed, leading to autoimmune disease.

He showed that injecting immune cells from healthy animals could prevent the illness—suggesting there was a system for blocking immune cells from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an inherited autoimmune disease in rodents and people that led to the discovery of a genetic factor vital for how regulatory T-cells function.

"The groundbreaking research has revealed how the immune system is kept in check by regulatory T cells, preventing it from accidentally attacking the healthy cells," said a leading biological science expert.

"The research is a striking example of how fundamental biological research can have far-reaching implications for human health."